[ACN Newswire] – By David MoskowitzQuestcor Pharmaceuticals (NASDAQ:QCOR) announced prescription trend data this morning for its primary revenue driver, H.P. Acthar Gel (Acthar), and the news is positive, sending the shares … moreView todays social media effects on QCORView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzBreaking news that health insurer, Oxford Health, will cover HP Acthar Gel (Acthar), looks like a major win for Questcor Pharmaceuticals (NASDAQ:QCOR), and the stock should rally once … moreView todays social media effects on QCORView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzBy now, the bear story on Questcor Pharmaceuticals (NASDAQ:QCOR) is well understood, with health insurer Aetna (NYSE:AET) indicating that it will make it next-to-impossible to get a prescription … moreView todays social media effects on QCORView the latest stocks trending across Twitter. Click to view dashboard […]
